FMP
Jul 29, 2024 8:53 PM - Davit Kirakosyan(Last modified: Jul 30, 2024 2:45 AM)
Image credit: FMP
Bristol-Myers Squibb (NYSE:BMY) shares surged over 11% on Friday after the pharmaceutical company reported strong second-quarter results, beating Wall Street's expectations for both earnings and revenue, and subsequently raised its full-year guidance.
The company posted EPS of $2.07, well above the Street estimate of $1.64. Revenue for the quarter reached $12.2 billion, exceeding the Street estimate of $11.52 billion. This marked a 9% increase from the same quarter last year.
Driving the strong performance was Bristol-Myers Squibb's Growth Portfolio, with revenues rising to $5.6 billion, an 18% jump. This growth was fueled by high demand for key products such as Opdivo, Reblozyl, Camzyos, and Opdualag, although it was partly offset by declines in Abecma. The Legacy Portfolio also saw a 2% increase in revenue, supported by Eliquis and Pomalyst, despite a drop in Revlimid sales due to generic competition.
Reflecting confidence in its growth trajectory, Bristol-Myers Squibb raised its full-year guidance. The company now anticipates adjusted EPS for 2024 to be in the range of $0.60 to $0.90, up from the previous forecast of $0.40 to $0.70, and significantly higher than the Street estimate of $0.51. Additionally, the company now expects full-year revenue to be at the upper end of the low single-digit range, an improvement over the previously forecast low single-digit increase.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 16, 2024 8:06 PM - Gordon Thompson
On Thursday, May 16, 2024, Deutsche Bank upgraded its rating on NASDAQ:ASTS to Buy, maintaining a hold position. At the time of the announcement, ASTS was trading at $4.03. This decision was accompanied by an increase in the price target for AST SpaceMobile, raised to $22 from $19, as detailed in a ...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...